Associations between folate, vitamin B12, homocysteine and pathologies related to aging: The need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 127-129

  Guéant, Jean Louis ^a,b   Elia, Maurizio ^b   Romano, Antonino ^b,c  

^a INSERM   (France)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AGING; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; FOOD INTAKE; GENETIC ASSOCIATION; HEALTH SURVEY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; ITALY; MULTIINFARCT DEMENTIA; NEUROGENIC BLADDER; NUTRIENT AVAILABILITY; PARKINSONISM; POPULATION RESEARCH; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; QUESTIONNAIRE; RIBOFLAVIN DEFICIENCY; SOCIOECONOMICS; THYROID DISEASE; THYROID FUNCTION; TREATMENT OUTCOME;

AGING; EPIDEMIOLOGY; FOLIC ACID; FOOD; GENES; HOMOCYSTEINE; HUMANS; SOCIOECONOMIC FACTORS; VITAMIN B 12;

EID: 33847167570     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.068     Document Type: Editorial

References (20)

1. De Beer J, De Jong A. National population scenarios for countries of the European Economic Area. Maandstat Bevolking 1996;44:7-19.
2. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999;48:445-69.
3. Fried LP. Epidemiology of ageing. Epidemiol Rev 2000;22:95-106.
4. Tucker KL, Buranapin S. Nutrition and ageing in developing countries. J Nutr 2001;131:2417S-23S.
5. WHO/FAO Expert Consultation. Diet, nutrition and the prevention of chronic diseases. Geneva: WHO, 2003.
6. Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Arnone G, et al. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Exp Gerontol 2004;39:443-50.
7. Ravaglia G, Forti P, Maioli F, Brunetti N, Martelli M, Talerico T, et al. Peripheral blood markers of inflammation and functional impairment in elderly community-dwellers. Exp Gerontol 2004;39:1415-22.
8. Clarke R. Commentary: an updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol 2002;31:70-1.
9. Erkkila AT, Lehto S, Pyorala K, Uusitupa MI. n-3 fatty acids and 5-y-risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003;78:65-71.
10. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996;121:231-43.
11. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005;94:907-15.
12. Piolot A, Blache D, Boulet L, Fortin LJ, Dubreiul D, Marcoux C, et al. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med 2003;141:41-9.
13. Song C, Horrobin D. Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1 beta administration. J Lipid Res 2004;45:1112-21.
14. Verhoef P, de Groot LC. Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med 2005;52:110-23.
15. Loscalzo J. Homocysteine trials - clear outcomes for complex reasons. N Engl J Med 2006;354:1629-32.
16. Vermeulen EG, Stehouwer CD, Valk J, van der Knaap M, ven den Berg M, Twisk JW, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial. Eur J Clin Invest 2004;34:256-61.
17. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593-600.
18. Lange N, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004;350:2673-81.
19. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al.; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88.
20. Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R, Riboli E, et al. Low folate levels may protect against colorectal cancer. Gut 2006;55:1461-6.